Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-27 @ 12:11 AM
Study NCT ID:
NCT07011550
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2025-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-05
First Submit QC Date:
None
Study First Post Date:
2025-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-20
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED